Expression plots across Trajectory 1 showed a progressive loss of naïve markers, gradual gain of dysfunctional (and senescent) markers and an intervening proliferative ‘burst’, that likely reflects expanding clones of tumor-targeting CD8+ cells (Fig. 4f). The gene discussed is CD8A; the disease is neoplasm.